Dr Marshall Fordyce (Vera Therapeutics)

  • shutterstock_1092755033
    Article

    Developing a new treatment paradigm for IgAN

    2024-03-14T11:49:10

    On World Kidney Day 2024, Dr Marshall Fordyce, CEO of Vera Therapeutics explores the challenges of treating kidney disease and shares why the company’s lead candidate could become the first self-administered B-cell modulation therapy.